Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
FNA.US
id: 1358

Paragon 28 (FNA) Financial Misrepresentation Case

D. Colorado
Court
1:24-cv-02712
Case number
05/05/2023
Class period Start
08/08/2024
Class period End
12/30/2024
Lead Plaintiff motion deadline
  • $FNA stockholders filed a claim against Paragon 28 for overstating inventory and downplaying costs, resulting in inaccurate financial statements.
  • After the news on July 30, 2024, $FNA dropped by over 13.7%.
  • $FNA investors can join this case to be notified about potential recovery.
Case Details:

On July 30, 2024, Paragon 28 revealed that its financial statements for 2023 and early 2024 contained errors and the company plans to restate both its annual and quarterly reports from that period.

On this news, $FNA fell by 13% on July 31, 2024.

Then, on August 8, 2024, Paragon 28 shared its Q2 results, cutting its yearly revenue outlook to $249-$255 million.

The company also announced plans to streamline operations, including a 7% staff reduction and changes to executive pay.

Following this news, $FNA dropped by 20% on the next day.

Based on these events, $FNA stockholders filed a claim against Paragon 28, accusing the company of the following:
  • The company hid issues with its financial reports.
  • It also failed to maintain adequate internal financial controls and overstated inventory while understating costs.
Considering all representations, investors believe that Paragon 28 misled them by overstating inventory, understating costs, and failing to maintain proper financial controls.
Case Status
Lead Plaintiff Submission
Alleged Offence
Mismanagement
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Suspected Party
Directors
Management
Shareholder
Security Type
Stocks
Trade Direction
Long
Shock Event Date
07/30/2024
Filing date
09/30/2024
Lead Plaintiff Deadline
12/30/2024
Collecting participants…

Paragon 28 Inc

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lis...

    Ticker
    FNA.US
    ISIN
    US69913P1057
    CIK
    1531978
    Sector
    Healthcare
    Industry
    Medical Devices
    Country
    USA
    Address
    14445 Grasslands Drive, Englewood, CO, United States, 80112